{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:01:40Z","timestamp":1773284500900,"version":"3.50.1"},"reference-count":28,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1179\/joc.2009.21.2.170","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T18:06:02Z","timestamp":1389290762000},"page":"170-180","source":"Crossref","is-referenced-by-count":38,"title":["Moxifloxacin for the Treatment of Patients with Complicated Intra-abdominal Infections (the AIDA Study)"],"prefix":"10.1080","volume":"21","author":[{"given":"G.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Reimnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Muehlhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lippert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1007\/s004230050089"},{"key":"CIT0002","first-page":"176","volume":"124","author":"Bruch HP","year":"1999","journal-title":"Zentralbl Chir"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-002-1383-6"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000087326.59341.51"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1086\/323333"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565120-00002"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl305"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200828020-00001"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1086\/378702"},{"key":"CIT0010","unstructured":"AVELOX\u00b0 tablets UK prescribing information, Bayer Schering Pharma, November 2007."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050465"},{"key":"CIT0012","first-page":"48","volume":"2004","author":"Edmiston CE","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","volume":"43","author":"Muller M","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh173"},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"Mayer-Bartschmid A, Schuhmacher J, D\u00f6rlemann S, Haas A. Determination of PK\/PD parameters of moxifloxacin against Bacteroides thetaiotaomicron in vitro at static and at varying drug concentrations. 17th European Congress of Clinical Micro-biology and Infectious Diseases and 25th International Congress of Chemotherapy, Munich, Germany, 31 March-3 April 2007, poster 1651.","DOI":"10.1016\/S0924-8579(07)71490-5"},{"key":"CIT0016","unstructured":"Glenschek-Sieberth M, Merfort K, Obertegger S, Kne2evie I, Endermann R. In vivo efficacy of moxifloxacin monotherapy against clinical isolates of B. fragilis with intermediate suscepti-bility. European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, 19-22 April 2008, poster 1065."},{"key":"CIT0017","unstructured":"Glenschek-Sieberth M, Merfort K, Obertegger S. A new animal model for severe complications of intra-abdominal infections: chronic uterus infections caused by B. fragilis. European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, 19-22 April 2008, poster 1932."},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1159\/000077806"},{"key":"CIT0019","unstructured":"Glenschek-Sieberth M, Mayer-Bartschmid A, Merfort K, Obertegger S, Hartke S, Haas M. In vivo and in vitro efficacy of moxifloxacin monotherapy against B. fragilis mutant strains with elevated MICs. 47th Annual Interscience Conference on Anti-microbial Agents and Chemotherapy, 17-20 September 2007, Chicago, USA, poster A-21."},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000230024.84190.a8"},{"key":"CIT0021","unstructured":"Solomkin JS, Zhao Y-P, Chen M-J, et al. Moxifloxacin IV is an effective empirical therapy for complicated intra-abdominal infections (cIAIs) - the DRAGON study. 16th Asian Surgical Bi-ennial Congress, 19-22 October 2007, Beijing, China."},{"key":"CIT0022","unstructured":"Lippert H, Weiss G, Choudhri SH, Herrington J, Briel-mann J-M. Clinical and bacteriological efficacy of sequential in-travenous (IV) to oral (PO) moxifloxacin in patients with complicated intra-abdominal Infections (cIAI) due to Enterobac-teriaceae. 20th European Congress on Surgical Infections, Frank-furt, Germany, 17\u201319 May 2007."},{"key":"CIT0023","unstructured":"Lippert H, Weiss G, Malangoni M, et al. Bacteriological efficacy of sequential intravenous (IV) to oral (PO) moxifloxacin for polymicrobial complicated intra-abdominal infections (cIAI). 20th European Congress on Surgical Infections, Frankfurt, Germany, 17\u201319 May 2007, abstract."},{"key":"CIT0024","unstructured":"Avelox IV US Prescribing Information, Bayer HealthCare and Schering-Plough, 2007."},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0011-393X(02)80086-8"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1997.01430360040008"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2028-2033.2000"},{"key":"CIT0028","first-page":"235","volume":"237","author":"Solomkin J","year":"2003","journal-title":"Ann Surg"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T04:50:10Z","timestamp":1565067010000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2009.21.2.170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1179\/joc.2009.21.2.170"],"URL":"https:\/\/doi.org\/10.1179\/joc.2009.21.2.170","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}